Literature DB >> 10581148

Studying the structure and regulation of soluble guanylyl cyclase.

D Koesling1.   

Abstract

Soluble guanylyl cyclase acts as the receptor for the signaling molecule nitric oxide. The enzyme consists of two different subunits. Each subunit shows the cyclase catalytic domain, which is also conserved in the membrane-bound guanylyl cyclases and the adenylyl cyclases. The N-terminal regions of the subunits are responsible for binding of the prosthetic heme group of the enzyme, which is required for the stimulatory effect of nitric oxide (NO). The five-coordinated ferrous heme displays a histidine as the axial ligand; activation of soluble guanylyl cyclase by NO is initiated by binding of NO to the heme iron and proceeds via breaking of the histidine-to-iron bond. Recently, a novel pharmacological and possibly physiological principle of guanylyl cyclase sensitization was demonstrated. The substance YC-1 has been shown to activate the enzyme independent of NO, to potentiate the effect of submaximally effective NO concentrations, and to turn carbon monoxide into an effective activator of soluble guanylyl cyclase. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581148     DOI: 10.1006/meth.1999.0891

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  14 in total

Review 1.  Soluble guanylate cyclases in the retina.

Authors:  Ari Sitaramayya
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

3.  Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus.

Authors:  Alain Burette; Ulrike Zabel; Richard J Weinberg; Harald H H W Schmidt; Juli G Valtschanoff
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Up-regulation of histidine decarboxylase expression and histamine content in B16F10 murine melanoma cells.

Authors:  Steven C Davis; Sheena Clark; J Robert Hayes; Todd L Green; Carl A Gruetter
Journal:  Inflamm Res       Date:  2010-07-18       Impact factor: 4.575

5.  In vitro and in vivo studies on the importance of the soluble guanylyl cyclase α1 subunit in penile erection.

Authors:  Kelly Decaluwé; Sofie Nimmegeers; Robrecht Thoonen; Emanuel Buys; Peter Brouckaert; Johan Van de Voorde
Journal:  World J Urol       Date:  2010-01-23       Impact factor: 4.226

6.  Human recombinant soluble guanylyl cyclase: expression, purification, and regulation.

Authors:  Y C Lee; E Martin; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

7.  Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.

Authors:  Guoying Zhang; Binggang Xiang; Anping Dong; Radek C Skoda; Alan Daugherty; Susan S Smyth; Xiaoping Du; Zhenyu Li
Journal:  Blood       Date:  2011-07-29       Impact factor: 22.113

8.  Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.

Authors:  Bradley A Maron; Ying-Yi Zhang; Diane E Handy; Annie Beuve; Shiow-Shih Tang; Joseph Loscalzo; Jane A Leopold
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

9.  A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.

Authors:  Emil Martin; Iraida Sharina; Alexander Kots; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

10.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.